SciSight Ecosystem
WoS SCIE Q2Scopus Q2SCImago #12,539CAS 4区Hybrid

Pharmaceutical Development and Technology

Abbreviation (ISO):PHARM. DEV. TECHNOL
Country: United States•WoS SCIE Quartile: Q2•Scopus SJR: 0.471•SCImago Rank: #12,539•Identifier (ISSN):1083-7450(Print)/1097-9867(Online)•Articles / Year: 83•Estimated Publication Fee (APC): $2,908 USD
Clarivate IF (2026)Q2
2.9
↑ +0.4

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
50

50 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
83articles/year
3.42% Gold OA•86.6% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 2.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.9)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.5)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.6)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.4)
🔵 Computed
20221.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.915)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.133)
🔵 Computed
20201.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.169)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.347)
🔵 Computed
20181.50đ
WoS Q2(IF: 1.945)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology. Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as: -Preformulation and pharmaceutical formulation studies -Pharmaceutical materials selection and characterization -Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation -QbD in the form a risk assessment and DoE driven approaches -Design of dosage forms and drug delivery systems -Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies -Drug delivery systems research and quality improvement -Pharmaceutical regulatory affairs This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.

Topics Covered (Recognized by AI)
Chemistry96.9%Biology90.3%Organic chemistry82.7%Materials science82.4%Engineering79.3%Physics72.4%Medicine72.3%Chemical engineering70.1%Chromatography70%Biochemistry62.3%Pharmacology58.5%Composite material55.3%Physical chemistry45.9%Nanotechnology41.2%Quantum mechanics39.9%Genetics37.1%Bioinformatics36.2%Thermodynamics34.1%Internal medicine33.6%Geology33.4%Nuclear magnetic resonance31.1%Psychology29.1%Polymer27.4%Paleontology26.3%Psychiatry25.6%Drug22.6%Drug delivery20.9%Dosage form20.8%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,539Scopus Q2SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.471

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
79

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.95

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,908 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations917
3-Year Documents288
Citable Documents284

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
Medicine (miscellaneous)Q3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Informa Healthcare
Publication Language
English
Frequency
Bimonthly
Founding Year
1996
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
173/356Q2
PHARMACOLOGY & PHARMACY
JCISCIE
135/356Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—6716
20252.5109270
20242.6107531
20233.485737
20223.915911,006
20213.133881,359
20202.1691122,360
20192.3471112,542
20181.945852,204
2017—1032,071
2016—1152,860
2015—1132,880
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Pharmaceutical Development and Technology

WoS Q2
1245201820192020202120222023202420252.50
Annual Impact Factor Metric
2025:2.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6519feb3-9f9d-4969-a0f7-5fa271944acd
Database Updated: 2026-09-28